Chris Shumway
Founder & Managing Partner at shumway-capital
Reviewed Updated Mar 19, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Chris Shumway is Founder and Managing Partner of Shumway Capital, which grew from $70M (2001) to $9B+ in AUM. Former Tiger Management Senior Managing Director; converted hedge fund to family office in 2011. His 17 verified investments cluster in healthcare (41%—Finch Therapeutics, Genoa, MyEyeDr), technology/fintech (24%), and consumer (12%). Invests with permanent capital base enabling decade+ investment horizons. Donated $50M+ to education and science.
Background
Chris Shumway is the Founder and Managing Partner of Shumway Capital, a private investment firm headquartered in Greenwich, Connecticut 1. He graduated from the University of Virginia’s McIntire School of Commerce in 1988 and earned an MBA from Harvard Business School in 1993 2.
After business school, Shumway joined Tiger Management, the legendary hedge fund founded by Julian Robertson Jr. 1. He became a Senior Managing Director and Management Committee member by age 30, serving from 1992 through 1999 2. Prior to Tiger, he had worked as an analyst at Morgan Stanley & Co. and at Brentwood Associates 2.
In 2001, Shumway founded Shumway Capital Partners, a global investment firm that grew from $70 million in assets to over $9 billion 1. From 2002 to 2011, the firm significantly outperformed the S&P 500 and received multiple recognitions from Barron’s as a top industry performer 1. In 2011, Shumway converted the firm from a hedge fund into a family office, stating he felt “responsible to correct this mismatch of investment style and investor needs” and that “the right decision for all of us is to return investor capital” 3. The conversion allowed for a more flexible investing mandate focused on long-term, opportunistic investments in both private and public securities 1.
Shumway has provided seed capital to startup investment managers including JAT Capital Management, Glade Brook Capital Partners, Tide Point Capital Management, and Trend Capital Management, which collectively manage in excess of $4 billion 4. He co-founded The Chris and Carrie Shumway Foundation in 2007, focused on poverty alleviation through education 2. He donated $25 million to the University of Virginia’s McIntire School of Commerce in 2018 and $25 million to Harvard Business School and Harvard’s Department of Stem Cell and Regenerative Biology in 2020 2 4.
Stated Thesis
Shumway Capital publicly describes its approach as targeting “high-quality businesses with strong management teams” focused on “long-term, sustainable growth and attractive reinvestment economics” 5. The firm states that as entrepreneurs themselves, they “understand the passion, vision and execution required to achieve sustainable growth” 1.
The firm emphasizes that its capital comes entirely from partners, providing “a permanent capital base that enables long-term investments and decision making” 6. Investment horizons can “extend well beyond typical funds’ and may last decades” 5. Shumway Capital states it works with management teams to “unlock growth through organic business opportunities and acquisitions” 5.
Inferred Thesis
Based on 17 verified private investments from Shumway Capital’s portfolio page and Crunchbase data, the following patterns emerge 5 7:
Sector Breakdown (17 verified investments): - Healthcare: Finch Therapeutics, Genoa Healthcare, CarepathRx, Elligo Health Research, MyEyeDr, Upstream Physical Therapy, Community Medical Group — 7 of 17 (41%) - Technology/Financial Infrastructure: Alibaba, TruMid, CLEAR Golf, Side — 4 of 17 (24%) - Consumer: Health-Ade, Bolthouse Farms — 2 of 17 (12%) - Mobility/Energy: Uber, ChargePoint — 2 of 17 (12%) - Sports/Culture: Premier Lacrosse League, Artsy — 2 of 17 (12%)
Stage Distribution: The portfolio skews toward growth-stage investments, with the firm describing its approach as spanning “all stages of the business lifecycle, from incubation to late-stage growth investing” 1. Average round size among tracked deals is approximately $45 million 7.
Geographic Focus: All verified private investments are in United States-based companies 7.
Notable Pattern — Healthcare Concentration: Despite claiming to invest across “all industries,” 41% of verified private investments are in healthcare, particularly healthcare services companies (not biotech/pharma). This is a significant stated-vs-actual gap.
Seed Capital to Fund Managers: Shumway has a distinct track record of seeding other hedge fund managers (JAT Capital, Glade Brook, Tide Point, Trend Capital), a “Tiger cub” pattern common among Julian Robertson’s alumni 4.
Portfolio
| Company | Stage | Year | Sector | Source |
|---|---|---|---|---|
| Alibaba | Growth | ~2014 | Technology | 5 |
| Uber | Growth | ~2015 | Mobility | 5 |
| TruMid Financial | Early Stage | 2015 | Fintech | 4 |
| Elligo Health Research | Series B | 2018 | Healthcare | 4 |
| Finch Therapeutics | Series B | 2018 | Healthcare/Biotech | 4 |
| Finch Therapeutics | Series C | 2019 | Healthcare/Biotech | 4 |
| Finch Therapeutics | Series D | 2020 | Healthcare/Biotech | 4 |
| ChargePoint | Growth | ~2020 | Energy/EV | 5 |
| Genoa Healthcare | Growth | ~2020 | Healthcare | 5 |
| CarepathRx | Growth | ~2020 | Healthcare | 5 |
| MyEyeDr | Growth | ~2020 | Healthcare | 5 |
| Artsy | Venture | 2021 | Art Marketplace | 8 |
| Premier Lacrosse League | Growth | ~2020 | Sports | 5 |
| Bolthouse Farms | Growth | ~2020 | Consumer/Agriculture | 5 |
| Health-Ade | Venture | 2025 | Consumer/Beverages | 7 |
| Side | Growth | ~2021 | Real Estate Tech | 5 |
| CLEAR Golf | Growth | ~2021 | Sports/Recreation | 5 |
Note: Dates marked with “~” are approximate, based on the firm’s portfolio page listing without specific investment dates. Shumway Capital’s private investment portfolio is broader than what is publicly documented.
In Their Own Words
Shumway has stated regarding his mentor Julian Robertson: “Julian was a brilliant investor, incredible mentor, amazing contributor to society and a great friend” 3.
On his decision to convert Shumway Capital to a family office in 2011, he wrote that he felt “responsible to correct this mismatch of investment style and investor needs” and stated that “the right decision for all of us is to return investor capital” 3.
Regarding his investment approach, Shumway Capital states on its website that the firm seeks to partner with management teams and emphasizes “the passion, vision and execution required to achieve sustainable growth” 1.
What Founders Say
No independently sourced founder testimonials found.
Sources
-
Shumway Capital website, “Team — Chris Shumway,” accessed March 2026. https://www.shumwaycapital.com/team/chris-shumway/↩↩↩↩↩↩↩↩
-
Business District, “Chris Shumway,” accessed March 2026. https://www.businessdistrict.com/chris-shumway/↩↩↩↩↩
-
Institutional Investor, “Lessons From Shumway’s Shutdown,” accessed March 2026. https://www.institutionalinvestor.com/article/2bsz8nnbw5wea2zxnf1fk/portfolio/lessons-from-shumways-shutdown↩↩↩
-
Shumway Capital website, “News,” accessed March 2026. https://www.shumwaycapital.com/news/↩↩↩↩↩↩↩↩
-
Shumway Capital website, “Private Investments,” accessed March 2026. https://www.shumwaycapital.com/our-approach/private-investments/↩↩↩↩↩↩↩↩↩↩↩↩↩↩
-
Shumway Capital website, homepage, accessed March 2026. https://www.shumwaycapital.com/↩
-
Unicorn Nest, “Shumway Capital — Investors Database,” accessed March 2026. https://unicorn-nest.com/funds/shumway-capital/↩↩↩↩
-
Crunchbase, “Shumway Capital — Investments,” accessed March 2026. https://www.crunchbase.com/organization/shumway-capital/recent_investments↩